[HTML][HTML] Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge
Abstract Ever-evolving SARS-CoV-2 variants of concern (VOCs) have diminished the
effectiveness of therapeutic antibodies and vaccines. Developing a coronavirus vaccine that …
effectiveness of therapeutic antibodies and vaccines. Developing a coronavirus vaccine that …
Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge.
CL Hsieh, SR Leist, EH Miller, L Zhou… - Nature …, 2024 - europepmc.org
Abstract Ever-evolving SARS-CoV-2 variants of concern (VOCs) have diminished the
effectiveness of therapeutic antibodies and vaccines. Developing a coronavirus vaccine that …
effectiveness of therapeutic antibodies and vaccines. Developing a coronavirus vaccine that …
Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge
CL Hsieh, SR Leist, EH Miller, L Zhou… - Nature …, 2024 - econpapers.repec.org
Abstract Ever-evolving SARS-CoV-2 variants of concern (VOCs) have diminished the
effectiveness of therapeutic antibodies and vaccines. Developing a coronavirus vaccine that …
effectiveness of therapeutic antibodies and vaccines. Developing a coronavirus vaccine that …
[PDF][PDF] Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge
CL Hsieh, SR Leist, EH Miller, L Zhou… - Nature …, 2024 - scienceopen.com
We first generated a base construct for S2-only antigens (HexaPro-S2) by removing the
entire S1 subunit from the HexaPro S protein (containing 6 stabilizing proline substitutions) …
entire S1 subunit from the HexaPro S protein (containing 6 stabilizing proline substitutions) …
[HTML][HTML] Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge
CL Hsieh, SR Leist, EH Miller, L Zhou… - Nature …, 2024 - ncbi.nlm.nih.gov
Abstract Ever-evolving SARS-CoV-2 variants of concern (VOCs) have diminished the
effectiveness of therapeutic antibodies and vaccines. Developing a coronavirus vaccine that …
effectiveness of therapeutic antibodies and vaccines. Developing a coronavirus vaccine that …
[PDF][PDF] Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge
CL Hsieh, SR Leist, EH Miller, L Zhou… - Nature …, 2024 - chandranlab.org
We first generated a base construct for S2-only antigens (HexaPro-S2) by removing the
entire S1 subunit from the HexaPro S protein (containing 6 stabilizing proline substitutions) …
entire S1 subunit from the HexaPro S protein (containing 6 stabilizing proline substitutions) …
Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge
CL Hsieh, SR Leist, EH Miller, L Zhou… - Nature …, 2024 - pubmed.ncbi.nlm.nih.gov
Ever-evolving SARS-CoV-2 variants of concern (VOCs) have diminished the effectiveness of
therapeutic antibodies and vaccines. Developing a coronavirus vaccine that offers a greater …
therapeutic antibodies and vaccines. Developing a coronavirus vaccine that offers a greater …
Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge
CL Hsieh, SR Leist, EH Miller, L Zhou… - Nature …, 2024 - ui.adsabs.harvard.edu
Abstract Ever-evolving SARS-CoV-2 variants of concern (VOCs) have diminished the
effectiveness of therapeutic antibodies and vaccines. Developing a coronavirus vaccine that …
effectiveness of therapeutic antibodies and vaccines. Developing a coronavirus vaccine that …
Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge
CL Hsieh, SR Leist, EH Miller, L Zhou… - Nature …, 2024 - ideas.repec.org
Ever-evolving SARS-CoV-2 variants of concern (VOCs) have diminished the effectiveness of
therapeutic antibodies and vaccines. Developing a coronavirus vaccine that offers a greater …
therapeutic antibodies and vaccines. Developing a coronavirus vaccine that offers a greater …
Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge
CL Hsieh, SR Leist, EH Miller, L Zhou… - Nature …, 2024 - einstein.elsevierpure.com
Abstract Ever-evolving SARS-CoV-2 variants of concern (VOCs) have diminished the
effectiveness of therapeutic antibodies and vaccines. Developing a coronavirus vaccine that …
effectiveness of therapeutic antibodies and vaccines. Developing a coronavirus vaccine that …